ACRO Statement on Release of 21st Century Cures Discussion Document

Contact: John Lewis
[email protected]

January 27, 2015 – WASHINGTON, DC – Doug Peddicord, Ph.D., Executive Director of the Association of Clinical Research Organizations (ACRO), released the following statement on the potential policy proposals unveiled today by House Energy and Commerce Committee Chairman Fred Upton (R-MI).

“ACRO commends Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO) for their thoughtfulness and diligence in leading the 21st Century Cures initiative. Today’s release of a discussion document provides the outline for a solid framework to improve not only the clinical trial process but the entire drug development enterprise for the benefit of patients. We are particularly encouraged by draft proposals to enhance data sharing and make greater use of real world evidence, streamline the review process for clinical trials, and make clinicaltrials.gov a more useable tool for patients, physicians and researchers. ACRO looks forward to the opportunity to further engage with Congress on these and other issues important to our members as the legislative process progresses.”

About ACRO
The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics, and medical devices. The Association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 100,000 professionals worldwide, conduct research in 142 countries and account for approximately two-thirds of contract clinical research revenue. For more information, please visit www.acrohealth.org. Twitter @acrohealth. YouTube @ACROHealthChannel. Facebook. RebelMouse.


Scroll to Top